Controlled Substance Export Permits for Psilocybin API: A Practical Guide

For psilocybin API manufacturers, the ability to export product to international customers is essential to commercial viability. But exporting a controlled substance across international borders is one of the most complex logistical and regulatory challenges in pharmaceutical manufacturing — involving multiple layers of licensing, documentation, and coordination between regulatory authorities in both the exporting and importing countries.

This article provides a practical overview of the controlled substance export permit process for psilocybin API, covering the international regulatory framework, the specific requirements under Thai law, the import permit process on the receiving end, and best practices for ensuring compliant international shipment.

The International Regulatory Framework

The international control of psilocybin is governed by the United Nations Convention on Psychotropic Substances (1971), which classifies psilocybin as a Schedule I substance. This classification requires all signatory nations to implement strict controls on the manufacture, distribution, and trade of psilocybin, including requirements for export and import authorization.

Under the Convention, the export of a controlled psychotropic substance requires:

• An export authorization issued by the competent authority of the exporting country
• An import authorization issued by the competent authority of the importing country
• Prior verification that the import authorization has been obtained before the export authorization is granted
• Notification to the International Narcotics Control Board (INCB) of both the export and import

This bilateral authorization system — sometimes called the "import-export" or "prior consent" system — is designed to ensure that controlled substances only move between countries when both governments have approved the transaction. It is the fundamental mechanism by which the international community prevents diversion of controlled substances to illicit channels.

Thailand's Export Licensing Framework

In Thailand, the export of controlled substances is regulated by the Narcotics Act B.E. 2522 (1979), as amended, and administered by the Office of the Narcotics Control Board (ONCB). The ONCB is Thailand's competent authority for issuing export permits for controlled substances, including psilocybin.

To export psilocybin API from Thailand, a manufacturer must hold:

Narcotics Manufacturing License (Form YS-5): This license, issued by the Thai FDA, authorizes the holder to manufacture controlled substances. It is a prerequisite for any export activity, as only licensed manufacturers can apply for export permits.

Export Permit (per shipment): Each individual export shipment requires a separate export permit issued by the ONCB. The permit application must include details of the consignment (quantity, purity, packaging), the consignee (name, address, licensing status), and the importing country's import authorization.

INCB Notification: The ONCB is responsible for notifying the INCB of each authorized export, in accordance with Article 12 of the 1971 Convention. This notification is typically handled by the ONCB as part of the export permit issuance process.

The Import Permit: The Other Side of the Equation

The export permit process cannot begin until the importing country has issued its own import authorization. This is a critical requirement — the ONCB will not issue an export permit without evidence that the destination country's competent authority has authorized the import.

The import permit process varies by jurisdiction, but generally follows a similar pattern:

United States (DEA): The U.S. Drug Enforcement Administration (DEA) issues import permits for Schedule I controlled substances under the Controlled Substances Import and Export Act. The importer must hold a DEA registration for Schedule I substances and submit DEA Form 357 (Application for Import Permit) for each import. The DEA coordinates with the INCB and the exporting country's authority.

European Union: In the EU, import permits for controlled substances are issued by the national competent authority of each member state. The specific requirements vary by country, but generally involve an application to the national drug regulatory agency demonstrating a legitimate medical or scientific purpose, valid licensing, and appropriate security measures.

United Kingdom (Home Office): The UK Home Office issues import licenses for controlled substances under the Misuse of Drugs Act 1971. Importers must hold a Home Office controlled drugs license and apply for a specific import license for each consignment.

Canada (Health Canada): Health Canada's Office of Controlled Substances issues import permits under the Controlled Drugs and Substances Act. Importers must hold a valid dealer's license and apply for an import permit through the online Controlled Substances Tracking System.

Australia (TGA): Following the rescheduling of psilocybin for therapeutic use in July 2023, the Therapeutic Goods Administration (TGA) administers import permits for psilocybin API under the Customs (Prohibited Imports) Regulations. Authorized importers must demonstrate compliance with GMP standards and hold appropriate licensing.

Documentation Requirements

A typical controlled substance export shipment of psilocybin API requires the following documentation:

• Export permit issued by the ONCB (original document accompanying the shipment)
• Import permit issued by the destination country's competent authority (copy provided to the ONCB, original may be required by customs)
• Certificate of Analysis (CoA) for the specific batch being exported, confirming identity, purity, and compliance with agreed specifications
• Commercial invoice detailing the product, quantity, value, and parties to the transaction
• Packing list with detailed contents of each shipping container
• Air waybill or bill of lading with appropriate dangerous goods and controlled substance declarations
• GMP certificate from the Thai FDA (may be requested by the importing country's authority)
• Chain of custody documentation maintaining a complete record of the substance from manufacture through shipment

Shipping and Logistics Considerations

The physical shipment of controlled substances requires careful logistical planning. Key considerations include:

Carrier selection: Not all freight carriers accept controlled substance shipments. Specialized pharmaceutical logistics providers with experience in controlled substance handling are typically required. Carriers must have appropriate security protocols, chain of custody procedures, and regulatory compliance capabilities.

Customs clearance: Controlled substance shipments are subject to inspection by customs authorities in both the exporting and importing countries. Proper documentation — including the original export permit and a copy of the import permit — must accompany the shipment to avoid delays or seizure.

Security: Controlled substance shipments must be secured against theft, diversion, and tampering. This typically involves sealed, tamper-evident packaging, GPS-tracked shipments, and direct delivery to the authorized consignee without intermediate storage.

Temperature control: While psilocybin API is relatively stable at ambient temperature, shipment under controlled temperature conditions (15–25°C) is recommended to maintain quality and comply with pharmaceutical shipping standards.

Best Practices for Compliant Export

Based on our experience navigating the controlled substance export process, we recommend the following best practices:

Start early: The combined export and import permit process can take 4–12 weeks, depending on the jurisdictions involved. Begin the permit application process well in advance of the desired shipment date.

Verify counterparty licensing: Before initiating any export transaction, verify that the prospective customer holds all necessary licenses and permits to import and handle controlled substances in their jurisdiction. Request copies of their DEA registration, Home Office license, or equivalent authorization.

Maintain complete records: Keep detailed records of every transaction, permit application, and shipment — including correspondence with regulatory authorities. These records are subject to audit by the ONCB, Thai FDA, and potentially by the importing country's authority.

Engage experienced logistics partners: Work with freight forwarders and customs brokers who have specific experience in pharmaceutical controlled substance shipments. Their expertise in documentation, customs procedures, and carrier selection can prevent costly delays and compliance issues.

Coordinate with regulatory authorities: Maintain open communication with the ONCB and the importing country's competent authority throughout the process. Proactive engagement can help resolve issues before they become obstacles.

The controlled substance export permit process is complex but navigable. Success depends on thorough preparation, complete documentation, and close coordination with regulatory authorities in both the exporting and importing countries. For manufacturers who master this process, the international market for pharmaceutical-grade psilocybin API represents a significant commercial opportunity.